73% of med spa patients are repeat patients. Flip the number: you lose about 1 in 4 every year. At 300 active patients, that's roughly 75 out the back door — and at the $285 median cost to acquire a new patient, about $21,000 a year in marketing spend just to maintain the status quo.
For a decade, growth forgave that leak. That era ended: when the market grows 1% and your zip code adds three competitors; retention is the whole game. You can't outspend the chains, and you shouldn't join them at $8 a unit.
Sources: AmSpa State of the Industry 2024 (73% repeat patients); Cakesmash Media 2026 ($285 median patient acquisition cost); Beauty Independent 2025 (market growth, saturation, $8/unit chains); OptiMantra 2026 (retained injectable patient value $1,600–$2,100/yr). We only publish numbers we can source — and we'll compute yours from your own books.
Toxin fades at 12–16 weeks. The average patient rebooks at 4.8 months. That drift costs about $250 per patient per year — and no calendar reminder knows when her toxin is actually fading.
Replacing an injector runs $50K–$100K — and her book leaves with her because the doses, placement, and response history live in her head. It's not disloyalty; the patient is loyal to the only person who knows her face.
Documented baselines and tracked results are your only real defense in a refund dispute or review threat and enforcement is rising. The same record that protects you is the one that could be earning rebookings.
Invisible on daily reports. Compounded on your annual bottom line.
The part everyone misses
All three leaks are the same leak: the most valuable data in your business evaporates the moment the appointment ends.
What he was treated with? How did his face respond? When did it actually wear off? What should happen next? Captured nowhere — or in one person's memory.
Not another booking system. Not a blast tool. Not an arbitrary reminder. The reminder is AI-driven analysis of the patient's own face.
Most patients scan at check-in, on an iPad or iPhone — no extra hardware. AI reads their facial anatomy: muscle position, movement, and wrinkle patterns, building a personal baseline for the visit.
LineRefine prompts each patient to rescan every few weeks. AI compares each scan to their peak, tracking real effectiveness — so rebooking is triggered by an actual fade, not a fixed calendar date.
The patient is prompted to rebook the moment it is actually needed — never on some arbitrary calendar. AI turns actual results into a personalized reference for your injector, so every visit is personalized, not a guess.
Who's due, who's overdue, who's been nudged, and the revenue you're retaining per patient. That's your ROI from LineRefine, updated in real time.
Toxin doesn't read your reminder schedule. Somewhere around week 14 she sees movement again, and whoever reaches her in that window gets the visit. LineRefine reaches her automatically, her own scans set the timing, and the prompt arrives with your booking link.
Doses, placement maps, response curves, and wear-off profiles live in your practice's record — not in one person's head. If a provider leaves, their replacement treats your patients like they've read the file. Because they did.
Every discounter has before-and-afters. Almost nobody has documented analysis, planning, and tracked results across the whole cycle — proof of process that justifies your full price, and gives every patient a visible record of their own results, visit over visit.
Our whole pitch is this math, so we publish it. Change every number to yours — the assumptions too. If your numbers don't clear breakeven, we'll tell you not to buy.
These are conservative pilot targets, not observed results — we're honest about that. Set them to whatever you believe.
LineRefine costs your band price, set by how many patients are engaged: $199, $349, or $499 a month. Unlimited injectors. No other fees exist to hide.
That's what's at stake — not what any tool recovers. Below is the conservative slice we model as recoverable.
Model notes: visits per year = 12 ÷ interval. On-time rebooking counts only patients who keep scanning between visits. Reactivated lapsed patients resume their prior cadence; each also avoids a ~$285 replacement acquisition. Benchmarks: AmSpa 2024, Cakesmash Media 2026, OptiMantra 2026. This is the same calculator we use in sales conversations — there isn't a different one.
One account for the whole practice. Adding patients and injectors costs nothing. Your monthly price is set by one number: how many patients are engaged — scanning at home between treatments, so you have visibility into how each result is holding and when it's time to bring the patient back. Patients who've gone quiet cost nothing until we bring them back.
Every patient, every injector, every scan. Add as many as you like.
Only pay for patients using LineRefine outside your office. What you're paying for is visibility into how each treatment holds post-visit. This count sets your band.
Free until we bring them back. When they rescan, they move back to engaged.
Example practice, matching the calculator's defaults. Your dashboard shows your own engaged count against your band, for example 180 of 350. You step up only after two months in a row over a line, and step down the first month you're under one.
One account. Everything included. No setup fees. No per-user fees. No feature tiers. No long contracts. Cancel anytime. And every month we send you the recovered-revenue math — who we nudged, who rebooked, what those visits were worth, and what each recovered visit cost you — so the fee is a receipt, not a leap of faith.
You don't have to believe any of this. You just have to be curious what your own number is.
Send a booking export; we send back your real rebooking interval, your lapsed patient pool, and what both are costing you. No product required. Yours to keep either way.
150 days at the band your leak analysis projects. Success criteria agreed in writing on day one, refunded if we miss them. Month to month after that.
Your patients aren't gone. They were just never told to come back.